Journal Guide
Publishing in Drugs: Fit, Timeline & Submission Guide
Drugs fits authoritative Reviews that help clinicians and clinical pharmacologists make prescribing decisions.
Should you submit here?
Best fit if
The proposed Review should help readers choose, monitor, sequence, compare, or avoid therapies
Not ideal if
A competent proposal can still be declined when the journal has recently covered the same clinical question
Also compare
Nearby journals in this field.
14.7
Impact Factor
Proposal and invitation led
Acceptance Rate
Presubmission inquiry before invited Review development
Time to First Decision
Readiness Scan
See whether your manuscript clears Drugs’s editorial screen.
Free 2 to 3 minute scan. Get a fit score, top issues, and the specific Drugs desk-reject patterns flagged before you submit.
Private API processing. Your manuscript is not used to train models.
What Drugs Publishes
Drugs publishes authoritative Reviews, Adis Drug Evaluations, and clinically relevant drug-therapy syntheses for physicians, clinical pharmacologists, and therapeutic-area specialists.
- Clinical-pharmacology Reviews with direct prescribing, safety, monitoring, or treatment-selection relevance
- Drug-class, drug-therapy, and Adis Drug Evaluation articles with strong author authority
- Topics with timely clinical value and a clear gap against recent coverage
Editor Insight
“Drugs readiness depends on topic timing, author authority, and whether the proposed Review is framed around a real clinical-prescribing decision.”
What Drugs Editors Look For
Clinical-prescribing relevance
The proposed Review should help readers choose, monitor, sequence, compare, or avoid therapies.
Author authority
The inquiry should show specific clinical-pharmacology or therapeutic-area expertise.
Topic timing
Authors should explain why the Review is needed now and how it differs from recent coverage.
Why Papers Get Rejected
These patterns appear repeatedly in manuscripts that don't make it past Drugs's editorial review:
Topic recently covered
A competent proposal can still be declined when the journal has recently covered the same clinical question.
Basic pharmacology framing
Drugs wants clinical-prescribing synthesis, not primarily molecular mechanism review.
Authority statement is generic
Editors need to know why this author team can guide the clinical-pharmacology decision.
Does your manuscript avoid these patterns?
The Free Readiness Scan reads your full manuscript against Drugs's criteria and flags the specific issues most likely to cause rejection.
Insider Tips from Drugs Authors
Start with the prescribing question
The inquiry should name the clinical decision the Review will improve.
Make the recent-coverage gap explicit
A short map of recent Drugs and Adis coverage helps show timing discipline.
The Drugs Submission Process
Topic timing
Before inquiryCheck recent Drugs and adjacent Adis coverage before drafting an unsolicited inquiry.
Prepare inquiry
Pre-inquiryDraft a concise outline, author-authority statement, clinical relevance argument, and reference map.
Contact editorial office
Day 0Submit the proposal or inquiry through the route listed on the current submission-guideline page.
Editorial appraisal
Initial screenEditors assess topic timing, clinical relevance, author authority, and portfolio fit.
Invited manuscript
After invitationIf encouraged, develop the Review, Drug Evaluation, or Therapy in Practice article for peer review.
Drugs by the Numbers
| Publisher | Springer Nature, Adis |
| Core format | Invited or proposal-led Reviews |
| Audience | Clinical pharmacology and prescribing clinicians |
Before you submit
Drugs accepts a small fraction of submissions. Make your attempt count.
Start with the Free Readiness Scan. Unlock the Full Review from $39, with local pricing shown before checkout. If you need deeper submission planning, choose the Submission-Ready Dossier. The full report is calibrated to Drugs.
Article Types
Review
Authoritative clinical-pharmacology or drug-therapy synthesis
Adis Drug Evaluation
Detailed evaluation of a drug or drug class
Therapy in Practice
Practice-focused clinical drug-therapy article
Landmark Drugs Papers
Papers that defined fields and changed science:
- Clinical drug-therapy Reviews
- Adis Drug Evaluations
- Therapy in Practice articles
Preparing a Drugs Submission?
Get pre-submission feedback from an AI engine trained by 35+ current journal reviewers, with Drugs as your target journal.
Run Free Readiness ScanWriting for a whole lab? See the Lab Plan
Primary Fields
Browse by Field
Ready to submit to Drugs?
A desk rejection costs months. Find the problems Drugs editors and reviewers are likely to flag while you can still fix them.